On October 6, 2025, Clearside Biomedical, Inc. confirmed it has regained compliance with Nasdaq's Minimum Bid Price Requirement by maintaining a stock price above $1.00 for 10 consecutive days, following a previously issued delisting notice in February 2025 due to non-compliance.